Skip to content

Investigating the effect of exercise on brain health in breast cancer patients

The Effect of Exercise on Cerebrovascular Function and Cognition in Breast Cancer Patients

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622000913774
Acronym
CaFog Study
Enrollment
40
Registered
2022-06-27
Start date
2022-06-22
Completion date
2025-04-28
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Cancer therapies are associated with significant adverse events, particularly cognitive impairment, where over 75% of breast cancer patients report cognitive impairment. As breast cancer occurs primarily in mid-life, this has created a large population of survivors who are at a unique intersection of both cancer and age-related effects on the brain, specifically declined brain blood vessel function and cognition. The aim of this study is to investigate the effects of a supervised 8-week multimodal exercise intervention on brain blood vessel and cognitive function in female breast cancer patients. Who is it for? You may be eligible for this study if you are a female breast cancer patient aged 40-80 years and you meet specific health requirements (blood pressure, heart health and cognitive/mental function). Study details Participants who choose to enrol in this study who are willing to undertake the exercise intervention program will be asked to complete a series of baseline measurements, before being invited to attend 2-3 x 1 hour exercise sessions each week for 8 weeks. Each sessions will include both aerobic exercises (e.g. stationary cycling, rowing) and muscle strength training (e.g. chest press and lat pulldown) and will be supervised by an Accredited Exercise Physiologist. One week after the completion of the exercise program, participants will be asked to complete the baseline measurements again for comparison. A second group of participants who are not wishing to participate in exercise at this point in time will also be invited to complete both the baseline and 9 week measurements for comparison. These participants will form the control group. Once the study has concluded, the control group will be provided with the exercise regime used in this study It is hoped this research will provide some evidence as to the effects of exercise therapy on cardiovascular, cerebrovascular and cognitive function in breast cancer patients. If this study is found to have a positive impact on the cardiovascular health and cerebrovascular and cognitive functions of these patients it may evolve into a larger randomised controlled trial to further examine the exercise effects in this population.

Interventions

The aim of this study is to conduct a pilot study that investigates the effects of a supervised 8-week multimodal exercise intervention on cerebrovascular and cognitive function in female breast cancer patients. This will be determined objectively by assessing the following outcomes: (1) Cerebrovascular function, determined by measuring the cerebrovascular responsiveness (CVR) to both physiological (hypercapnia; 5% carbon dioxide) and psychological stimuli (cognitive battery) (2) Cognitive func

The aim of this study is to conduct a pilot study that investigates the effects of a supervised 8-week multimodal exercise intervention on cerebrovascular and cognitive function in female breast cancer patients. This will be determined objectively by assessing the following outcomes: (1) Cerebrovascular function, determined by measuring the cerebrovascular responsiveness (CVR) to both physiological (hypercapnia; 5% carbon dioxide) and psychological stimuli (cognitive battery) (2) Cognitive function, determined by a battery of individual cognitive tasks that are summated to reflect total cognitive capacity. Study design and ethical considerations An 8-week quasi-randomised, controlled-trial of female breast cancer patients (n=24) who will be assigned to either a multimodal exercise intervention or waitlist group (control) will be conducted collaboratively at the University of Southern Queensland (USQ) Toowoomba, The Fit Lab Toowoomba, and Queensland X-ray Toowoomba. Participants will visit USQ, The Fit Lab and Queensland X-ray prior to the commencement of the study, to establish baseline measurements. Participants will undergo anthropometric (body weight, height, hip, and waist circumference), functional capacity (60s sit-to-stand, 400m walk) and strength testing measurements under the supervision of an Accredited Exercise Physiologist at The Fit Lab. Dual-energy X-ray absorptiometry will be used to determine body composition measurements (lean and fat mass, bone mineral content and density) of the participants at Queensland X-Ray by an accredited technician. Participants will undergo cerebrovascular, cognitive, and cardiovascular measurements at USQ. Cognition will be measured via an iPad using the Trail Making Task Parts A and B, Spatial Span Test and the National Institute of Health (NIH) Toolbox. . Cerebrovascular measurements will be measured non-invasively using transcranial Doppler ultrasonography (TCD). These measurements include CVR to physiological (hypercapnia; 5% carbon dioxide) and cognitive stimuli. Hypercapnia will require participants to breath a gas containing 5% carbon dioxide and 21% oxygen in a balance of nitrogen gas for 3 minutes following breathing room air for 1 minute prior, via a two-way non-rebreathing valve whilst wearing a nose-clip. The CVR to cognitive stimuli will be assessed during individual cognitive tasks and summated to achieve a total composite CVR to cognitive stimuli. Finger photoplethysmography (human non-invasive blood pressure and haemodynamic monitor) will be used to measure cardiovascular function, with heart rate and arterial blood pressure being measured on a continuous beat-to-beat basis. Participants will complete a validated nutritional questionnaire to estimate energy intake over a typical 24 h period to ensure any changes observed in the primary outcomes are primarily due to the effects of exercise and not changes in nutritional behaviour. Additionally, participants will complete the Profile of Mood States (POMS) questionnaire to calculate total mood disturbance. All measurements, as well as the Yale Physical Activity Survey (YPAS) and POMS, will be repeated 1 week following the completion of the study at a similar time of day to their baseline measurements. Exercise intervention Participants allocated to the exercise group will participate in a supervised multimodal exercise program for up to three sessions per week for 8 weeks. The exercise intervention is an established program delivered externally by Accredited Exercise Physiologists at The Fit Lab. It has been adapted from previous research that has validated the safety of exercise interventions in patients with breast cancer (Cormie et al. 2013; Casla et al. 2015). Each session will comprise aerobic exercise and muscle strength training (i.e. multimodal exercise training) and last for approximately 60 min, including a 5 min warm-up and 5 min cool down. Aerobic exercise training will involve, for example, rowing, walking on a treadmill and riding a stationary bike. Examples of muscle strength exercises include chest press, lat pulldown and leg press. These would be expected to be performed at a moderate to vigorous intensity. The exercise session swill be conduction in person in groups of no more than 12 people. The exercise sessions will be self-paced, with progressive overload techniques put in place to ensure exercise capacity and muscle strength progression. An attendance sheet will be used to determine participant compliance to the intervention.

Sponsors

University of Southern Queensland
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Be aged 40-80 years Female breast cancer patient Have blood pressure below 160/100mmHg (we will determine this at the screening visit) Have an adequate ultrasound signal (we will determine this at the screening visit). Not have heart condition (e.g. congestive heart failure) or a neurological disorder (e.g. stroke)

Exclusion criteria

Cognitive impairment and/or dementia Resting blood pressure equal to or greater than 160/100mmHg Coronary heart disease Congestive heart failure Atrial fibrillation Prior myocardial infarction Stroke Aneurysm Epilepsy Multiple sclerosis Parkinson’s disease Neuropathies Presence of a fistulae Smoker Middle cerebral artery signal absent on Doppler ultrasound

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 15, 2026